After melanoma surgery, Bristol's Opdivo offers new care standard

MADRID (Reuters) - Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients who have had surgery to remove disease, researchers reported on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news